1.400USD+1.400After-hours 07/29, 20:00 (ET)
1.25BMarket Cap
LossP/E TTM
Key Figures
1.380Open
1.730High
34.59MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
4.56%Turnover Ratio
1.240Prev. Close
1.370Low
40.13MTurnover
LossP/E Static
0.99P/B
0.00%Div Yield TTM
-10.69%ROA
1.60052wk High
11.08Volume Ratio
-53.22MNet Profit
759.07MShares
-0.2721EPS TTM
1.47Beta
-16.92%ROE
0.97752wk Low
29.03%Amplitude
-58.39%Gross Margin
1.25BMarket Cap
-7.66Reward/Risk
2.33%Risk Rate
Currency: USD Updated: 2026-07-28 Key Insights
OPKO Health Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 37 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 4.38.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
OPKO Health Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
OPKO Health Inc Highlights
StrengthsRisks
OPKO Health Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
OPKO Health Inc Info
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Ticker SymbolOPK
CompanyOPKO Health Inc
CEOCruz (Tony F)
Website
Shareholders
FAQs
What is the current price of OPKO Health Inc (OPK)?
The current price of OPKO Health Inc (OPK) is 1.65.
What is the symbol of OPKO Health Inc?
The ticker symbol of OPKO Health Inc is OPK.
What is the 52-week high of OPKO Health Inc?
The 52-week high of OPKO Health Inc is 1.60.
What is the 52-week low of OPKO Health Inc?
The 52-week low of OPKO Health Inc is 0.98.
What is the market capitalization of OPKO Health Inc?
The market capitalization of OPKO Health Inc is 1.25B.
Is OPKO Health Inc (OPK) currently rated as Buy, Hold, or Sell?
According to analysts, OPKO Health Inc (OPK) has an overall rating of Buy, with a price target of 4.38.
What is the Earnings Per Share (EPS TTM) of OPKO Health Inc (OPK)?
The Earnings Per Share (EPS TTM) of OPKO Health Inc (OPK) is -0.30.
